bromopyruvate has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bränström, R; Chen, Z; Cui, HL; Gao, J; Huang, WK; Larsson, C; Li, S; Lui, WO; Shi, H; Yeh, CN; Yuan, J | 1 |
1 other study(ies) available for bromopyruvate and Gastrointestinal Stromal Neoplasm
Article | Year |
---|---|
Heterogeneity of Metabolic Vulnerability in Imatinib -Resistant Gastrointestinal Stromal Tumor.
Topics: Antimycin A; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Energy Metabolism; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Glycolysis; Gossypol; Humans; Imatinib Mesylate; Oligomycins; Organelle Biogenesis; Oxidative Phosphorylation; Phenotype; Pyruvates | 2020 |